Medicines Safety Improvement Programme (MedSIP)
The Medicines Safety Improvement Programme (MedSIP) aims to reduce severe avoidable medication related harm by 50% by March 2024 through medicines optimisation and quality improvement.
The team delivered a system-wide pain and opioid face-to-face event: Feeling the Pain which was held on in November 2022. | |
The event attracted 85 delegates, from various disciplines, who came together to share their practices and experiences of chronic pain management. | |
The event hosted the launch of the NENC Pain Clinical Network. |
Management of ‘chronic non-cancer pain’ requires personalised care and shared decision making at its core with patients requiring a mixture of biopsychosocial support. A whole system approach is being implemented into the programme to support people to live well with their ‘chronic non-cancer pain’. The team linked with partners across the NENC Integrated Care System (ICS) to facilitate this.
The overall aim is to facilitate the identification of priority areas, share intelligence and good practice, learning and resources and support the reduction of overall opioid prescribing.
The NENC region already have numerous initiatives being carried out within the ICS to reduce opioid prescribing and associated risk. The NENC patient safety collaborative facilitate and support a holistic approach to the identification of patients from areas of high deprivation, high health inequalities and/or high opioid prescription rates within the ICS with the aim of reducing overall total patients prescribed an opioid and overall total number of patients on high dose opioids.
After the success and level of engagement with various stakeholders across the NENC region in 2022-23 the team delivered a system-wide pain and opioid face-to-face event: Feeling the Pain which was held on in November 2022.
National and regional speakers presented an overview of the opioid problem in the North East and North Cumbria; its impact on public health, personal experiences of opioid prescribing and novel ways of managing pain and its sequelae.
The event attracted 85 delegates, from various disciplines, who came together to share their practices and experiences of chronic pain management.
The event hosted the launch of the NENC Pain Clinical Network – NENC ICS has emphasised the value of clinical networks in supporting the development of clinical strategy and to encourage adoption of best practice over a large and diverse geographic area.
The event agenda, presentations, workshop and poster details can be found on this link: ‘Feeling the Pain: Reducing Harm Caused by Opioids for Non-Cancer Pain’